NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000717

Registered date:01/06/2007

Efficacy of rosuvastatin for the treatment of nonalcoholic steatohepatitis with hyperlipidemia

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiednonalcoholic fatty liver disease
Date of first enrollment2007/06/01
Target sample size50
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary Outcomeliver transaminases
Secondary Outcome1.liver histology, 2.adipocytokines,3.liver fibrosis marker,4.glucose metabolism

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1.patient with previous administration of rosuvastatin 2.patient with other origin of hepatitis than NASH 3.patient with allergy for rosuvastatin 4.patient with severe liver damage or obstructive biliary disease 5.patient recieving cyclosporin. 6. pregnancy

Related Information

Contact

public contact
Name Hideyuki Hyogo
Address Japan
Telephone 082-257-5190
E-mail hidehyogo@aol.com
Affiliation Graduate School of Biomedical Sciences, Hiroshima University. Department of Medicine and Molecular Science
scientific contact
Name Kazuaki Chayama
Address Kasumi1-2-3, Minamiku, Hiroshima city, Hiroshima,Japan. 734-8551 Japan
Telephone 082-257-5190
E-mail
Affiliation Graduate School of Biomedical Sciences, Hiroshima University. Department of Medicine and Molecular Science